Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1254)	2/19/1999 7:31:00 PM
From: margie	Read Replies (1) \| Respond to of 2539

NBC Nightly News-- has a very positive feature on Celebrex Lifeline ~6:30 PM EST The drug will be officially launched Monday, but it is already causing a sensation; there is a feeding frenzy, with patients demanding prescriptions, wanting safer treatment. Dr. Steven Magio says it offers the potential to give patients drugs that are known to work, but without the side effects of anti-inflammatory drugs. The demand is so great that analysts estimate a $4 billion market for Cox-II inhibitors in a few years and over 140,000 prescriptions have been written so far for Celebrex, the most popular new drug since Viagra.